When delivered locally, BDNF limits the death of TH+ dopaminergic neurons in the SNc that normally accompanies the injection of 6-OHDA into the striatum [42,43,44,45]; to this end we have tested if the systemic administration of TXB4-TrkB is neuroprotective in this model of PD. This evidence concerns the gene BDNF and Parkinson disease.